Visualize HL7 Example and Test Instances (vi7eti)

Visualize HL7 Example and Test Instances (vi7eti), pronounced /viːˈsɛtiː/

Disclaimer: FOR TEST AND EXAMPLE PURPOSES ONLY! These web pages are not intended to be used as a source of information on on healthcare or medicines. The web pages are not kept up to date and are for demonstration purposes only. For up-to-date information on a medicine, please consult www.ema.europa.eu/medicines or the package leaflet of your medicine. For up-to-date information on other healthcare topics, please consult the relevant reliable sources or an healthcare expert, such as a physician etc.

BACK TO LIST

Patient
Name:	Markošová, Alan
DOB:	17-MAR-1941 (Age: 85)
Gender:	male
Address:	Na Hrebienku 53 980 45 Vladiča (Slovakia)
ID:	3171-766886-2 (ECI)

Report
Date:	27-OCT-2018

Laboratory
dr Ample, Ex Laboratoire Central Européenne Boulevard du Jardin Botanique 32 1000 Brussels (Belgium)

Requested by
Detská fakultná nemocnica s poliklinikou Banská Bystrica Námestie Ludvíka Svobodu 4 974 01 Banská Bystrica (Slovakia)

Specimen
Collected:	26-OCT-2018

Hematology

Test	27-OCT-2018	Reference Range	Unit
Leukocytes [#/volume] in Blood by Automated count	6.4	4.5 - 11.0	10*3/uL
Erythrocytes [#/volume] in Blood by Automated count	5.2	4.3 - 5.7	10*6/uL
Hemoglobin [Mass/volume] in Blood	15.7	13.5 - 17.5	g/dL
Hematocrit [Volume Fraction] of Blood by Automated count	36.0	36 - 50	%
MCV [Entitic mean volume] in Red Blood Cells by Automated count	80.6	80 - 100	fL
MCH [Entitic mass] by Automated count	29.1	27 - 33	pg
MCHC [Entitic Mass/volume] in Red Blood Cells by Automated count	35.4	32 - 36	g/dL
Erythrocyte distribution width [Entitic volume] by Automated count	42.9	36 - 46	fL
Platelets [#/volume] in Blood by Automated count	299.8	150 - 450	10*3/uL
Platelet distribution width [Entitic volume] in Blood by Automated count	387.7 H	9.9 - 17.2	fL
Platelet [Entitic mean volume] in Blood by Automated count	9.4	6.4 - 11.2	fL

Chemistry

Test	27-OCT-2018	Reference Range	Unit
Hemoglobin A1c/Hemoglobin.total in Blood	6.2 H	4.8 - 5.9	%
Glucose [Mass/volume] in Blood	89.2	70 - 100	mg/dL
Urea nitrogen [Mass/volume] in Blood	12.3	7 - 20	mg/dL
Creatinine [Mass/volume] in Blood	0.7	0.7 - 1.3	mg/dL
Calcium [Mass/volume] in Blood	9.4	8.5 - 10.5	mg/dL
Sodium [Moles/volume] in Blood	139.5	135 - 145	mmol/L
Potassium [Moles/volume] in Blood	3.7	3.5 - 5.1	mmol/L
Chloride [Moles/volume] in Blood	103.4	98 - 110	mmol/L
Carbon dioxide, total [Moles/volume] in Blood	25.5	22 - 29	mmol/L
Cholesterol [Mass/volume] in Serum or Plasma	127.1	125 - 200	mg/dL
Triglyceride [Mass/volume] in Serum or Plasma	144.3	0 - 149	mg/dL
Cholesterol in LDL [Mass/volume] in Serum or Plasma by Direct assay	45.1	0 - 100	mg/dL
Cholesterol in HDL [Mass/volume] in Serum or Plasma	53.2	40 - 60	mg/dL

Annotation

Conclusion and Recommendations based on this report and previous findings known to us
Laboratory results are largely within normal limits. Notable findings include mildly elevated HbA1c (6.2%), suggesting impaired glucose tolerance or possible diabetes, and a markedly high platelet distribution width, which may indicate increased platelet size variability and warrants clinical correlation. No evidence of anemia, renal dysfunction, or significant dyslipidemia. Recommend monitoring glycemic control and further evaluation of platelet morphology if clinically indicated.

Conclusion and Recommendations based on this report and previous findings known to us

Laboratory results are largely within normal limits. Notable findings include mildly elevated HbA1c (6.2%), suggesting impaired glucose tolerance or possible diabetes, and a markedly high platelet distribution width, which may indicate increased platelet size variability and warrants clinical correlation. No evidence of anemia, renal dysfunction, or significant dyslipidemia. Recommend monitoring glycemic control and further evaluation of platelet morphology if clinically indicated.